Tatiana Valentinovna Tiutiunnik

Tatiana Valentinovna Tiutiunnik

Auto-generated profile, based on publicly available information

Tatiana Valentinovna Tiutiunnik

Department of Physiology (Pavlov’s), Institute of Experimental Medicine, Saint Petersburg, Russia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2024 in Toxicology Mechanisms and Methods
Verified
Journal Article
Closed access
VKValentina Mikhailovna Kudrinskaya
Valentina Mikhailovna Kudrinskaya
AIAndrey Pavlovich Ivlev
Andrey Pavlovich Ivlev
DODaria Obukhova
Daria Obukhova
VMViktoriya Maystrenko
Viktoriya Maystrenko
TTTatiana Valentinovna Tiutiunnik
Tatiana Valentinovna Tiutiunnik
IIIrina Sergeevna Ivleva
Irina Sergeevna Ivleva
Chronic exposure to manganese compounds leads to accumulation of the manganese in the basal ganglia and hippocampus. High levels of manganese in these structures lead to oxidative stress, neuroinflammation, imbalance of brain neurotransmitters, and hyperactivation of calpains mediating neurotoxicity and causing motor and cognitive impairment. The purpose of this work was to study the effect of excess manganese chloride intake on rats' spatial memory and on dopamine-β-hydroxylase (DβH) activity under conditions of calpain activity suppression. Rats were divided into 3 groups of 10 animals each. Group 1 received MnCl2 (30 days, 5 mg/kg/day, intranasally), group 2 received MnCl2 (30 days, 5 mg/kg/day, intranasally) and calpain inhibitor Cast (184-210) (30 days, 5 µg/kg/day, intranasally), and group 3 received sterile saline (30 days in a volume of 20 μl, intranasally). The spatial working memory was assessed using Morris water maze test. DβH activity was determined by HPLC. We have shown that in response to excessive intake of MnCl2, there was a development of cognitive impairments in rats, which was accompanied by a decrease in DβH activity in the hippocampus. The severity of cognitive impairment was reduced by inhibiting the activity of m-calpain. The protective effect of calpain inhibitors was achieved not through an effect on DβH activity. Thus, the development of therapeutic regimens for the treatment of manganism using dopaminomimetics and/or by inhibiting calpains, must be performed taking into account the manganese-induced decrease of DβH activity and the inability to influence this process with calpain inhibitors.

25 May 2025 in European Journal of Neuroscience
Verified
Journal Article
Closed access
TTTatiana Valentinovna Tiutiunnik
Tatiana Valentinovna Tiutiunnik
VKValentina Mikhailovna Kudrinskaya
Valentina Mikhailovna Kudrinskaya
DODaria Obukhova
Daria Obukhova
VVValeria Andreevna Vilnikova
Valeria Andreevna Vilnikova
VBViktoria Olegovna Burdinskaya
Viktoria Olegovna Burdinskaya
MKMarina Karpenko
Marina Karpenko

4 March 2026 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
TTTatiana Valentinovna Tiutiunnik
Tatiana Valentinovna Tiutiunnik
DODaria Obukhova
Daria Obukhova
VVValeria Andreevna Vilnikova
Valeria Andreevna Vilnikova
ZMZamira Muruzheva
Zamira Muruzheva
MKMarina Karpenko
Marina Karpenko

29 October 2024 in Medical academic journal
Verified
Journal Article
Closed access
PDF file
ANAlexandra A. Nikitina
Alexandra A. Nikitina
SBSvetlana G. Belokoskova
Svetlana G. Belokoskova
VMViktoriya Maystrenko
Viktoriya Maystrenko
NPNina Pestereva
Nina Pestereva
TTTatiana V. Tyutyunnik
Tatiana V. Tyutyunnik
ЦГЦикунов Сергей Георгиевич
Цикунов Сергей Георгиевич
BACKGROUND: Arginine vasopressin has been implicated in the modulation of stress and pain. The influence of a synthetic analogue of arginine vasopressin, 1-deamino-8-D-arginine-vasopressin, оn pain sensitivity, stress reactivity, levels of monoamines and brain neurotrophic factor in a model of paw electrical stimulation in rats has not been studied. AIM: The aim was to evaluate the effect of a synthetic vasopressin analog, 1-deamino-8-D-arginine-vasopressin, on pain sensitivity and the content of norepinephrine, serotonin, dopamine, brain neurotrophic factor in the parietal cortex and spinal cord in electrocutaneous paw stimulation test in rats. MATERIALS AND METHODS: The study was conducted on male Wistar rats who were injected with 1-deamino-8-D-arginine-vasopressin intranasally once a day for 5 days in small (single 20 ng, course 100 ng) and large doses (single 2 ug, course 10 ug). The content of brain neurotrophic factor in the parietal cortex and spinal cord, and corticosterone in blood serum were determined using enzyme immunoassay. The levels of norepinephrine, serotonin, dopamine and their metabolites in the brain were evaluated using high-performance liquid chromatography. RESULTS: 1-Deamino-8-D-arginine-vasopressin in different doses reduced pain sensitivity in rats, more pronounced when administered in large doses. The peptide in small doses in the parietal cortex increased the content of dopamine and reduced the levels of 5-hydroxyindolacetic acid, a metabolite of serotonin; in the spinal cord, it reduced the content of 5-hydroxyindolacetic acid. 1-Deamino-8-D-arginine-vasopressin in high doses in the parietal cortex increased the content of dopamine and reduced the levels of 5-hydroxyindolacetic acid; in the spinal cord ― reduced the content of serotonin and 3,4-dihydroxyphenylacetic acid, a metabolite of dopamine; increased the levels of norepinephrine and homovanilic acid, a metabolite of dopamine. The peptide had no effect on corticosterone levels in the blood and brain neurotrophic factor levels in the brain in rats. CONCLUSIONS: The analgesic effects of 1-deamino-8-D-arginine-vasopressin were revealed with intranasal administration in different subendocrine doses. Regardless of the administered doses, dopamine and serotonin at the supraspinal level were involved in peptide-induced anesthesia; serotonin at the spinal cord level. More pronounced analgesia with the administration of 1-deamino-8-D-arginine-vasopressin in high doses was due to the additional involvement of dopamine and norepinephrine at the spinal cord level.

31 May 2025 in Medical academic journal
Verified
Journal Article
Closed access
PDF file
ELElena Ya. Lebedeva
Elena Ya. Lebedeva
EKEkaterina S. Kukushkina
Ekaterina S. Kukushkina
TTTatiana V. Tyutunnik
Tatiana V. Tyutunnik
VMViktoriya Maystrenko
Viktoriya Maystrenko
ТВТютюнник Татьяна Валентиновна
Тютюнник Татьяна Валентиновна
МАМайстренко Виктория Александровна
Майстренко Виктория Александровна
BACKGROUND: Experimental endotoxemia, based on the injection of lipopolysaccharide, is used to study systemic inflammation. Glucocorticosteroids, such as methylprednisolone and dexamethasone, play a key role in modulating inflammation. They affect inflammatory mediators and cellular components, penetrating the blood-brain barrier. However, the cerebral effects of glucocorticosteroids are not well studied. The assessment of behavioral changes induced by lipopolysaccharide and glucocorticosteroids using the “open field” test will help explore the neurobiological mechanisms of inflammation and stress. AIM: Study of the effect of glucocorticosteroids on behavioral and physiological changes induced by experimental endotoxinemia in rats. METHODS: Six groups of Wistar rats, 10 males in each group, were used in the experiment. The first group was injected once intraperitoneally with physiological solution, the second group was injected with lipopolysaccharide (1 mg/kg), the 3rd group was injected with i/p dexamethasone, 2 mg/kg; the 4th group was injected with i/p dexamethasone, 2 mg/kg, 2 h before lipopolysaccharide injection; the 5th group was injected with i/p methylprednisolone, 2 mg/kg; the 6th group was injected with i/p methylprednisolone, 2 mg/kg, 2 h before lipopolysaccharide injection. During the first 4 h of the experiment, deep body temperature of the rats was measured every 30 min and after 24 h to construct a temperature curve. At several time points, the behavior and locomotor activity of the rats were evaluated in the open-field test. RESULTS: The results obtained demonstrate that lipopolysaccharide administration causes changes in behavioral patterns such as stance, minking, locomotion, act of grooming and frizzing. No differences were found in the effects of glucocorticosteroid depending on the drug. Application of glucocorticosteroid promotes restoration of motor activity of animals, elimination of negative effects of lipopolysaccharide. CONCLUSION: The studied glucocorticosteroid drugs dexamethasone and methylprednisolone had comparable anti-inflammatory effect in terms of severity, caused normalization of body temperature and eliminated behavioral changes caused by lipopolysaccharide.

24 December 2024 in Medical academic journal
Verified
Journal Article
Open access
PDF file
TTTatiana V. Tiutiunnik
Tatiana V. Tiutiunnik
VKValentina M. Kudrinskaya
Valentina M. Kudrinskaya
DODaria Obukhova
Daria Obukhova
VMViktoriya Maystrenko
Viktoriya Maystrenko
NPNina Pestereva
Nina Pestereva
ОАОбухова Дарья Алексеевна
Обухова Дарья Алексеевна
BACKGROUND: Glucocorticoids play an important role in the development of the stress response in the organism. Synthetic glucocorticoids such as dexamethasone are widely used in medicine due to their anti-inflammatory effects. However, there is evidence that glucocorticoid-based drugs used in sufficiently high doses can induce pro-inflammatory effects by affecting predominantly the hippocampus in the central nervous system as the most plastic brain structure. It is important to note that the dose, route and timing of administration can affect the effects of glucocorticoids, and it is therefore an important biomedical task to choose the optimal parameters of glucocorticoid administration in order to achieve the most effective treatment results. AIM: The aim of our study was to investigate the effect of peripheral administration of a synthetic glucocorticoid, dexamethasone, at a dose of 8 mg/kg on the development of neuroinflammation in the rat hippocampus at different periods after administration. MATERIALS AND METHODS: Thirty-two sexually mature male Wistar rats distributed into 8 groups of 4 animals each were used in the experiment. The animals were injected with dexamethasone at a dose of 8 mg/kg and decapitated for different periods (1, 3, 9, 12, 18, 24, 48 hours — time of decapitation after administration), group К — control group with saline injection). Further, the cytokine profile expression was analyzed by real-time reverse transcription polymerase chain reaction method. RESULTS: In this study, we found an increase in the expression of proinflammatory cytokines AIF1 (IBA-1) and IL-1β after 12 and TNF-α after 24 hours after dexamethasone administration at a dose of 8 mg/kg, which may indicate a neuroinflammatory effect of dexamethasone at this dose. It should be noted that the level of NF-êB gene, a marker of inflammation, remained unchanged, possibly due to the activation of compensatory mechanisms to control inflammation or stress. CONCLUSIONS: The increase in mRNA of inflammatory markers IL-1β, TNF-α and AIF1, in the hippocampus after 12 hours after single dexamethasone administration to rats at a dose of 8 mg/kg may indicate a switch of the effect of this drug from antiinflammatory to proinflammatory, which should be taken into account when dexamethasone is used such a treatment during several diseases.